[go: up one dir, main page]

DK1380590T3 - Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf - Google Patents

Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Info

Publication number
DK1380590T3
DK1380590T3 DK03292131T DK03292131T DK1380590T3 DK 1380590 T3 DK1380590 T3 DK 1380590T3 DK 03292131 T DK03292131 T DK 03292131T DK 03292131 T DK03292131 T DK 03292131T DK 1380590 T3 DK1380590 T3 DK 1380590T3
Authority
DK
Denmark
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
new method
Prior art date
Application number
DK03292131T
Other languages
English (en)
Inventor
Thierry Dubuffet
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1380590T3 publication Critical patent/DK1380590T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK03292131T 2003-08-29 2003-08-29 Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf DK1380590T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03292131A EP1380590B1 (fr) 2003-08-29 2003-08-29 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (1)

Publication Number Publication Date
DK1380590T3 true DK1380590T3 (da) 2007-01-08

Family

ID=29724623

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03292131T DK1380590T3 (da) 2003-08-29 2003-08-29 Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Country Status (19)

Country Link
US (1) US7183308B1 (da)
EP (1) EP1380590B1 (da)
JP (1) JP4331205B2 (da)
CN (1) CN100395264C (da)
AR (1) AR045515A1 (da)
AT (1) ATE338766T1 (da)
AU (1) AU2004270427B2 (da)
CY (1) CY1105790T1 (da)
DE (1) DE60308102T2 (da)
DK (1) DK1380590T3 (da)
EA (1) EA008485B1 (da)
ES (1) ES2272922T3 (da)
MY (1) MY139348A (da)
NZ (1) NZ545335A (da)
PL (1) PL211509B1 (da)
PT (1) PT1380590E (da)
SI (1) SI1380590T1 (da)
WO (1) WO2005023841A1 (da)
ZA (1) ZA200601428B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2252633T3 (es) * 2003-08-29 2006-05-16 Les Laboratoires Servier Nuevo procedimiento de sintesis de perindopril y de sus bases farmaceuticamente aceptables.
WO2005108365A1 (en) * 2004-05-07 2005-11-17 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
EP1987828A1 (en) 2005-01-06 2008-11-05 IPCA Laboratories Limited salts of perindopril and their use in the therapy of hypertension
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
CN108752259A (zh) * 2018-07-04 2018-11-06 南京方生和医药科技有限公司 培哚普利消旋体及其中间体的制备方法
CN112047998B (zh) * 2020-09-07 2024-01-09 上海阿达玛斯试剂有限公司 一种培哚普利的制备方法
CN113980096A (zh) * 2021-11-29 2022-01-28 绍兴市上虞区武汉理工大学高等研究院 一种吨级培哚普利叔丁胺的合成工艺方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
SI1319668T1 (en) * 2003-03-12 2005-02-28 Les Laboratoires Servier Method for synthesis of (2S,3aS,7aS)-1-((S)-alanyl)-octahydro-1H-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril
ATE294814T1 (de) * 2003-03-12 2005-05-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
DE60301820T2 (de) * 2003-08-29 2006-07-13 Les Laboratoires Servier Verfahren zur Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salze

Also Published As

Publication number Publication date
ATE338766T1 (de) 2006-09-15
US20070043103A1 (en) 2007-02-22
PL211509B1 (pl) 2012-05-31
AU2004270427B2 (en) 2008-08-21
HK1096409A1 (en) 2007-06-01
EA008485B1 (ru) 2007-06-29
ES2272922T3 (es) 2007-05-01
AU2004270427A1 (en) 2005-03-17
ZA200601428B (en) 2007-05-30
JP2007526901A (ja) 2007-09-20
EA200600456A1 (ru) 2006-08-25
MY139348A (en) 2009-09-30
PT1380590E (pt) 2006-12-29
AR045515A1 (es) 2005-11-02
CN100395264C (zh) 2008-06-18
DE60308102D1 (de) 2006-10-19
SI1380590T1 (sl) 2006-12-31
DE60308102T2 (de) 2007-06-21
WO2005023841A1 (fr) 2005-03-17
PL379629A1 (pl) 2006-10-30
EP1380590A1 (fr) 2004-01-14
US7183308B1 (en) 2007-02-27
CY1105790T1 (el) 2011-02-02
NZ545335A (en) 2009-08-28
CN1839147A (zh) 2006-09-27
JP4331205B2 (ja) 2009-09-16
EP1380590B1 (fr) 2006-09-06

Similar Documents

Publication Publication Date Title
DK1268424T3 (da) Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte
DK1483284T3 (da) Selektive dipeptidinhibitorer af kallikrein
DK1362864T3 (da) Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
IS7402A (is) Ný kristölluð form atorvastatínhálfkalsíums og aðferðir til að framleiða þau, auk nýrra aðferða tilað framleiða atorvastatínhálfkalsíum form I, VIIIog IX
DK1367061T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1420028T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1380590T3 (da) Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
IS7424A (is) Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær
DK1321471T3 (da) Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf
DK1348684T3 (da) Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
DK1371659T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1380591T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf
DK1420029T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1367062T3 (da) Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1403275T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1367063T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1753720T3 (da) Fremgangsmåde til fremstilling af perindopril og salte deraf
DK1422236T3 (da) Syntesefremgangsmåde for perindopril og farmaceutisk acceptable salte heraf
DK1440067T3 (da) N-formyl-derivater af paroxetin
DK1515959T3 (da) Farmaceutiske salte af reboxetin
NO20063067L (no) Fremgangsmate og anordning for finskjaering av plater
IS6234A (is) Ný lyfjaform og aðferðir við tilreiðslu þeirra
DK1385850T3 (da) Nye fremgangsmåder til fremstilling af oxabispediner
NO20035378D0 (no) Fremgangsmåte og anordning for separatpåf degree ring
ITSV20030025A1 (it) Dispositivo e metodo per la riproduzione fotografica di